指南与共识神经与头颈病理细胞病理与分子病理

甲状腺癌病理报告数据集:国际癌症报告协作组推荐

Data set for reporting carcinoma of the thyroid: recommendations from the International Collaboration on Cancer Reporting.
指南 / 共识 · Hum Pathol · 2020-09-10

国际癌症报告协作组(ICCR)组织国际专家小组,基于最新文献与专家意见制定了甲状腺癌病理报告标准化数据集。该数据集采用最新WHO分类,强调血管侵犯范围和甲状腺外扩展对风险分层的重要性,首次要求报告核分裂活性和肿瘤坏死,并突出评估淋巴结病变体积以预测复发风险,推荐全球常规使用。

要点

  • 采用最新WHO分类,微浸润性滤泡癌仅限包膜侵犯的肿瘤。
  • 首次要求报告核分裂活性和肿瘤坏死等预后参数。
  • 强调评估淋巴结病变体积以预测复发风险。

核心结论

  • ICCR甲状腺数据集为生成更合理指导患者治疗的病理报告提供工具,旨在防止侵袭性恶性肿瘤治疗不足并避免惰性肿瘤过度治疗。
  • 推荐在国际上常规使用该数据集报告甲状腺癌组织学。

研究设计与样本

  • 国际专家小组审查甲状腺病理报告的每个要素,基于最新文献和专家意见提出建议。

主要发现

  • 数据集使用最新WHO分类以实现更具临床和预后相关性的命名,例如将微浸润性滤泡癌限制为仅有包膜侵犯的肿瘤。
  • 强化了最新WHO分类和美国武装部队病理研究所分册采用的血管侵犯标准。
  • 强调血管侵犯范围和甲状腺外扩展对患者治疗分层的重要性。
  • 首次要求病理学家使用新近认识的预后有力参数:核分裂活性和肿瘤坏死。
  • 突出评估淋巴结病变体积对预测复发风险的重要性。

关键数值与推荐

  • 微浸润性滤泡癌仅限包膜侵犯的肿瘤。
  • 强化最新WHO分类和AFIP分册采用的血管侵犯标准。
  • 首次要求报告核分裂活性和肿瘤坏死。
  • 强调评估淋巴结病变体积以预测复发风险。

临床怎么用

  • 病理科医生应常规使用ICCR甲状腺数据集报告甲状腺癌组织学,以指导更合理的患者治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Thyroid cancer therapy is increasingly tailored to patients' risk of recurrence and death, placing renewed importance on pathologic parameters. The International Collaboration on Cancer Reporting (ICCR), an organization promoting evidence-based, internationally agreed-upon standardized pathology data sets, is the ideal conduit for the development of a pathology reporting protocol aimed at improving the care of patients with thyroid carcinomas. An international expert panel reviewed each element of thyroid pathology reporting. Recommendations were made based on the most recent literature and expert opinion.The data set uses the most recent World Health Organization (WHO) classification for the purpose of a more clinically and prognostically relevant nomenclature. One example is the restriction of the term minimally invasive follicular carcinoma to tumors with capsular invasion only. It reinforces the already established criteria for blood vessel invasion adopted by the most recent WHO classification and Armed Forces Institute of Pathology fascicle. It emphasizes the importance of the extent of blood vessel invasion and extrathyroid extension to better stratify patients for appropriate therapy. It is the first data set that requires pathologists to use the more recently recognized prognostically powerful parameters of mitotic activity and tumor necrosis. It highlights the importance of assessing nodal disease volume in predicting the risk of recurrence.The ICCR thyroid data set provides the tools to generate a report that will guide patient treatment in a more rational manner aiming to prevent the undertreatment of threatening malignancies and spare patients with indolent tumors the morbidity of unnecessary therapy. We recommend its routine use internationally for reporting thyroid carcinoma histology.

来源:Hum Pathol,查看原文。版权归原作者所有。

引用

  1. Ghossein R, Barletta JA, Bullock M, et al. Data set for reporting carcinoma of the thyroid: recommendations from the International Collaboration on Cancer Reporting. Hum Pathol. 2020. PMID: 32920035. doi:10.1016/j.humpath.2020.08.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。